After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs ...

PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

In recent weeks, researchers have announced several breakthroughs in treatment for pancreatic cancer. Researchers in New York ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Researchers report encouraging long-term results from an experimental treatment approach that rethinks the timing of cancer ...

Researchers announced three major cancer advances, including a novel dual-action drug for pancreatic cancer, new insights into CAR T-cell therapy failures, and the FDA's real-time clinical trial ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

CLEVELAND, Ohio — The benefits of getting regular exercise, combining two cancer drugs with chemotherapy, and using AI to ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses ...

Promising new research suggests a triple threat approach could help treat pancreatic cancer. Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of ...

Lehi, Utah, April 16, 2026 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced ...